Currently out of the existing stock ratings of Charles Rhyee, 179 are a BUY (82.49%), 35 are a HOLD (16.13%), 3 are a SELL (1.38%).

Charles Rhyee

Work Performance Price Targets & Ratings Chart

Analyst Charles Rhyee works at TD COWEN with a stock forecast success ratio of 68.76% fulfilled within 303.77 days on average. Previously, Charles Rhyee worked at COWEN.

Charles Rhyee’s has documented 431 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GDRX, Goodrx Holdings at 01-Mar-2024.

Wall Street Analyst Charles Rhyee

Analyst best performing recommendations are on CSLT (CASTLIGHT HEALTH).
The best stock recommendation documented was for CSLT (CASTLIGHT HEALTH) at 8/4/2021. The price target of $1.9 was fulfilled within 1 day with a profit of $0.16 (7.77%) receiving and performance score of 77.67.

Average potential price target upside

of $68.37 (38.33%) on CI (CIGNA CORP).
of $63.44 (17.24%) on HUM (HUMANA).
of $54.13 (21.21%) on UNH (UNITEDHEALTH GROUP ORPORATED).

ABC AmerisourceBergen CERN Cerner Corp CHNG Change Healthcare CI Cigna Corp CSLT Castlight Health CVS CVS Health Corp DRIO DarioHealth Corp EVH Evolent Health GDRX Goodrx Holdings HUM Humana MCK McKesson MDRX Allscripts Healthcare Solutions OTRK Ontrak OWLT Owlet RAD Rite Aid SNCE Science 37 Holdings TDOC Teladoc WBA Walgreens Boots Alliance AMWL American Well Corp RCM R1 RCM CAH Cardinal Health PEAR Pear Therapeutics HLTH Cue Health CNC Centene Corp UNH UnitedHealth Group orporated ATHN athenahealth BTTX Better Therapeutics MOH Molina Healthcare VEEV Veeva Systems WBMD WebMD Health Corp IQV IQVIA Holdings TALK Talkspace CRL Charles River Laboratories

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Charles Rhyee (TD COWEN)